Ultra-rapid site activation and subject consent in PARPi Study using Tempus TIME Program

The TIME program enabled activation of a new clinical trial site within 4 business days for a PARPi study. Read on to learn how the patient was able to dose within 10 days of being identified as a match for the trial.

Feb 03, 2023
Life Sciences
Case Study